Cannabis Strategic Ventures

OTC: NUGS · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Los Angeles, CA · Los AngelesCIK 0001290504Reports USD

#1025 of 1,422 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ 2GM —SS 47

v0.1 · 25/100 weight · pillars only

↑ return on assets, net margin · ↓ disclosure history, Piotroski F

Methodology →

Revenue TTM

$4.8M

Rev growth YoY (TTM)

-29.3%

Net income (FY)

$11.8k

Employees

as of 2026-08-27

Market cap

$368.4k

as of 2026-08-27

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$149.6k$149.6k2014

Net income$11.8k$11.8k2014

Operating income$11.8k$11.8k2014

Total assets$2.8k$2.8k2014

Liabilities$58.8k$58.8k2014

Equity-$56.0k-$56.0k2014

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Cannabis Strategic Ventures’s revenue?

Cannabis Strategic Ventures booked $149.6k in FY2014 revenue, contracting 60% year over year — slower than 84% of Healthcare companies we track, at a 7.9% net margin.

Peers · Healthcare

Kalaris Therapeutics Inc30D Curative Biosciences, Inc.——ZIVO Bioscience, Inc.——Anthera Pharmaceuticals, Inc.——VivoSim Labs, Inc.——Sigyn Therapeutics, Inc.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B72B Public Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68B Live Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D

Key facts

CEOSimon Yu

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersLos Angeles, CA

ExchangeOTC: NUGS

Employees30

IPO date2009-07-24

Latest filings

10-K2015-02-17 10-Q2015-02-10 8-K2014-11-28 8-K2014-06-17 8-K2014-05-27 8-K2007-06-11 8-K2006-09-22 8-K2006-07-17

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.